國立虎尾科技大學 |

Cell and Gene Therapies

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Cell and Gene Therapies/ edited by Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard.
其他作者:	Perales, Miguel-Angel.
面頁冊數:	VI, 288 p. 12 illus., 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Hematology. -
電子資源:	https://doi.org/10.1007/978-3-319-54368-0
ISBN:	9783319543680

Cell and Gene Therapies
Cell and Gene Therapies[electronic resource] /edited by Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard. - 1st ed. 2019. - VI, 288 p. 12 illus., 11 illus. in color.online resource. - Advances and Controversies in Hematopoietic Transplantation and Cell Therapy,2569-1376. - Advances and Controversies in Hematopoietic Transplantation and Cell Therapy,.

Historical perspective and current focus -- Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects -- Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges -- Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges -- Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges -- T-cell receptors-gene modified T-cells for cancer -- Methods, data and challenges. -- Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to “off the shelf” -- Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability -- Tumor infiltrating lymphocytes: Current concepts and practices -- Part III: Beyond T-cells: Natural killer cells: What have we learned?- Dendritic cells in hematopoietic cell transplantation -- Mesenchymal stem cells: From bench to bedside and back -- Cell Therapies: Regulatory concerns and data collection -- Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting -- Gene therapy for nonmalignant disorders -- Future prospects of cell and gene therapies.

In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee.

ISBN: 9783319543680

Standard No.: 10.1007/978-3-319-54368-0doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Cell and Gene Therapies
LDR:03786nam a22003975i 4500 001 1012084
003 DE-He213
005 20200701023111.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783319543680 $9 978-3-319-54368-0
024 7 $a 10.1007/978-3-319-54368-0 $2 doi
035 $a 978-3-319-54368-0
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Cell and Gene Therapies $h [electronic resource] / $c edited by Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a VI, 288 p. 12 illus., 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances and Controversies in Hematopoietic Transplantation and Cell Therapy, $x 2569-1376
505 0 $a Historical perspective and current focus -- Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects -- Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges -- Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges -- Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges -- T-cell receptors-gene modified T-cells for cancer -- Methods, data and challenges. -- Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to “off the shelf” -- Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability -- Tumor infiltrating lymphocytes: Current concepts and practices -- Part III: Beyond T-cells: Natural killer cells: What have we learned?- Dendritic cells in hematopoietic cell transplantation -- Mesenchymal stem cells: From bench to bedside and back -- Cell Therapies: Regulatory concerns and data collection -- Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting -- Gene therapy for nonmalignant disorders -- Future prospects of cell and gene therapies.
520 $a In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee.
650 0 $a Hematology. $3 645254
650 0 $a Oncology . $3 1253469
650 2 4 $a Oncology. $3 593951
700 1 $a Perales, Miguel-Angel. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1306341
700 1 $a Abutalib, Syed A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1112907
700 1 $a Bollard, Catherine. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1306342
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319543673
776 0 8 $i Printed edition: $z 9783319543697
830 0 $a Advances and Controversies in Hematopoietic Transplantation and Cell Therapy, $x 2569-1376 $3 1284590
856 4 0 $u https://doi.org/10.1007/978-3-319-54368-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)